Showing 1 - 10 of 16
Can ethical supply chains survive tariffs?
Oped, Joleen Ong, Published on 10/10/2025
» Recent geopolitical developments have underscored the fragility of global supply chains, reminding businesses in constantly evolving sectors like consumer goods and fashion that the strength of supplier relationships is one of the few persistent sources of resilience. Maintaining such relationships through responsible purchasing is not only ethical but strategically necessary.
Clock ticks as plastic talks drag on
Oped, Pichmol Rugrod, Published on 13/08/2025
» This week in Geneva, negotiators from around the world are gathered for the fifth session of the Global Plastics Treaty -- known as INC 5.2. It is an intergovernmental process aimed at finding solutions to the plastic pollution crisis. Yet, more than a week in, progress toward a strong and binding agreement remains painfully slow. As the clock ticks, our window to act is rapidly closing.
How China and Japan's values 'differ'
Oped, Philip J Cunningham, Published on 05/12/2024
» Malaysia's former prime minister Mahathir Mohamad famously saluted "Asian values" citing "diffidence" as one of the characteristics that ostensibly made Asians different, though he did so in an arrogant, attention-grabbing kind of way. More successful was his "Look East Policy", (which, from the geographic confines of Malaysia is actually the Philippines) and there was no mistaking that it was Japan that Mr Mahathir had in mind, with China hovering somewhere out of focus in the background.
Treaty a chance to solve plastic crisis
Oped, Salisa Traipipitsiriwat and Penchom Saetang, Published on 21/11/2024
» Plastic pollution is a massive problem that needs to be solved collectively at the global level.
US must reform antitrust and patent laws now
Oped, Mordecai Kurz, Published on 09/02/2024
» When the United States enacted the Sherman Antitrust Act in 1890, Senator John Sherman offered a famous justification: "If we will not endure a king as a political power, we should not endure a king over the production, transportation, and sale of any of the necessities of life. If we would not submit to an emperor, we should not submit to an autocrat of trade, with power to prevent competition and to fix the price of any commodity".
The molecular line between life and death
Oped, Gwynne Dyer, Published on 01/03/2023
» 'We are but one very small company [among] many hundreds of companies using AI software for drug discovery and de novo design. How many of them have ... the know-how to find the pockets of chemical space that can be filled with molecules predicted to be orders of magnitude more toxic than VX?" This is a warning that requires a little explanation.
US CHIPS off the Chinese block
Oped, Anne O. Krueger, Published on 23/08/2022
» Semiconductors, one of the most important innovations of the last century, are now crucial inputs in mobile phones, personal computers, educational technologies, vehicles, heavy machinery, medical instruments, military equipment and much more.
'Spywaregate' needs answers
Oped, Published on 23/07/2022
» The National Human Rights Commission and other related agencies must step in to examine allegations that the government has routinely used phone spyware to surveil dozens of politicians and pro-democracy activists known for playing active roles in demanding the reform of major institutions.
Funding the fight against NCDs
Oped, Stephen Ogweno, Published on 08/07/2022
» Non-communicable diseases (NCDs), such as cardiovascular disease, cancer, lung disease, diabetes, obesity and mental disorders, are often chronic and develop over a long period. Collectively, NCDs account for about 70% of all deaths globally (and 60% of deaths in Sub-Saharan Africa, where they account for over 55% of hospital admissions in countries such as Kenya). Developing countries thus face a double burden of illness, with communicable diseases like malaria, HIV, and tuberculosis still presenting a huge challenge alongside the rising incidence of NCDs.
Covid carousel
Oped, Postbag, Published on 04/12/2021
» Re: "B1 trillion to beat Omicron", (BP, Dec 3).